HIV cure: Knocking on the door

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 5, 2013, Pages 382-384

  Durand, C M ^a   Flexner, C ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

^c Division of Clinical Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTIVIRUS AGENT; BRYOSTATIN; DISULFIRAM; HEXAMETHYLENEBISACETAMIDE; PROSTRATIN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; VORINOSTAT;

BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; DRUG TOLERABILITY; GENE THERAPY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; LATENT PERIOD; PRIORITY JOURNAL; REVIEW;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HUMANS; VIRUS LATENCY;

EID: 84876523578     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.22     Document Type: Review

References (9)

1. Richman, D.D., Margolis, D.M., Delaney, M., Greene, W.C., Hazuda, D. & Pomerantz, R.J. The challenge of finding a cure for HIV infection. Science 323, 1304-1307 (2009).
2. Barton, K.M., Burch, B.D., Soriano-Sarabia, N. & Margolis, D.M. Prospects for treatment of latent HIV. Clin. Pharmacol. Ther. 93, 46-56 (2013).
3. + T cell model without inducing global T cell activation. J. Virol. 85, 6060-6064 (2011).
4. + T cell model without inducing global T cell activation. J. Antimicrob. Chemother. 67, 398-403 (2012).
5. Shan, L. et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491-501 (2012).
6. Archin, N.M. et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487, 482-485 (2012).
7. Hutter, G. et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692-698 (2009).
8. + count-guided interruption of antiretroviral treatment. N. Engl. J. Med. 355, 2283-2296 (2006).
9. Henrich, T.J. et al. Long-term reduction in peripheral blood HIV-1 reservoirs following reduced-intensity allogeneic stem cell transplantation in two HIV-infected individuals. Presented at XIX International AIDS Society Conference, 22-27 July 2012, Washington, DC.